Market Cap 59.81M
Revenue (ttm) 0.00
Net Income (ttm) -8.88M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 456,600
Avg Vol 504,954
Day's Range N/A - N/A
Shares Out 31.65M
Stochastic %K 96%
Beta -4.09
Analysts Strong Sell
Price Target $13.25

Company Profile

OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS...

Industry: Biotechnology
Sector: Healthcare
Phone: 410-297-7793
Address:
115 Pullman Crossing Road, Suite 103, Grasonville, United States
TeaBaggerVance
TeaBaggerVance Oct. 28 at 12:28 AM
$OSTX Maybe we open over $2 tomorrow? 🙏
0 · Reply
Indycolts2004
Indycolts2004 Oct. 28 at 12:25 AM
$OSTX a little overnight action to 2.04. We’ll take it
0 · Reply
flywithfitz81
flywithfitz81 Oct. 27 at 8:18 PM
$PSTV $OSTX I think at this point I should be on both boards. When are we getting rich guys?
0 · Reply
flywithfitz81
flywithfitz81 Oct. 27 at 8:10 PM
$OSTX $2.07 tonight.
1 · Reply
Miketj
Miketj Oct. 27 at 7:48 PM
$OSTX let’s start taking out those DMAs and get this SP moving north😎
0 · Reply
flywithfitz81
flywithfitz81 Oct. 27 at 7:04 PM
$OSTX I don't know why, but i bought another 12k shares at 1.89 earlier. Guess I am feeling lucky.
0 · Reply
flywithfitz81
flywithfitz81 Oct. 27 at 5:55 PM
$OSTX Base Case: Catalysts timeline that could impact price Upcoming biomarker data (immune activation correlation) expected in upcoming months. Stock Titan+1 Further regulatory meetings (e.g., with EMA, MHRA) and potential submission of BLA/MAA. Stock Titan+1 Potential commercialization / partnership announcements if approval pathway advances. Market reaction to any negative surprise (e.g., regulatory push-back, dilution) could cause sharp move downward. Price prediction: Under the base scenario, OSTX goes from ~US$1.90 today to: ~US$3.00 in 30 days ~US$4.00 in 60 days ~US$5.50 in 90 days ~US$7.50 in 180 days This assumes positive regulatory/bio data, maintain runway, no major negative surprises. If a major partnership or accelerated path is confirmed, the upside could be much higher (bull scenario). Conversely, any regulatory setback or dilution risk could send the price lower (bear scenario). https://www.stocktitan.net/news/OSTX/?utm_source=chatgpt.com
1 · Reply
MadMaverick
MadMaverick Oct. 27 at 5:05 PM
🚨 Biotech traders, watch $OSTX Game-changing data just dropped: 🧬 2-year Overall Survival: → 73.8% for lung-only mets vs. → 30% historical comparator (p < 0.0001) 📅 Regulatory meetings with MHRA, FDA & EMA slated for Dec. 2025 ⚡️ Fast-track potential for osteosarcoma + solid tumor therapies This could be a pivotal moment in rare cancer treatment. Communicated Disclaimer - https://stockresearchtoday.com/groundbreaking-treatments-for-solid-tumors/ Other stocks moving up today: $CODX $CLIK $BKYI
0 · Reply
LioGod
LioGod Oct. 27 at 4:27 PM
$OSTX damn could we see a 2$?
0 · Reply
Orlandotrader
Orlandotrader Oct. 27 at 3:46 PM
$OSTX Could we finally be on the Ascent!!!
0 · Reply
Latest News on OSTX
OS Therapies to Participate in Fall 2025 Conferences and Events

Oct 7, 2025, 11:50 AM EDT - 20 days ago

OS Therapies to Participate in Fall 2025 Conferences and Events


OS Therapies Terminates Equity Line of Credit

Aug 25, 2025, 9:51 PM EDT - 2 months ago

OS Therapies Terminates Equity Line of Credit


OS Therapies Provides Clinical & Global Regulatory Updates

Jul 10, 2025, 7:40 AM EDT - 3 months ago

OS Therapies Provides Clinical & Global Regulatory Updates


OS Therapies FDA Meeting Request Granted

Apr 22, 2025, 7:40 AM EDT - 6 months ago

OS Therapies FDA Meeting Request Granted


OS Therapies to Host Analyst Day at NYSE on April 7, 2025

Apr 2, 2025, 7:40 AM EDT - 7 months ago

OS Therapies to Host Analyst Day at NYSE on April 7, 2025


OS Therapies Provides Corporate Update

Feb 4, 2025, 7:33 AM EST - 9 months ago

OS Therapies Provides Corporate Update


TeaBaggerVance
TeaBaggerVance Oct. 28 at 12:28 AM
$OSTX Maybe we open over $2 tomorrow? 🙏
0 · Reply
Indycolts2004
Indycolts2004 Oct. 28 at 12:25 AM
$OSTX a little overnight action to 2.04. We’ll take it
0 · Reply
flywithfitz81
flywithfitz81 Oct. 27 at 8:18 PM
$PSTV $OSTX I think at this point I should be on both boards. When are we getting rich guys?
0 · Reply
flywithfitz81
flywithfitz81 Oct. 27 at 8:10 PM
$OSTX $2.07 tonight.
1 · Reply
Miketj
Miketj Oct. 27 at 7:48 PM
$OSTX let’s start taking out those DMAs and get this SP moving north😎
0 · Reply
flywithfitz81
flywithfitz81 Oct. 27 at 7:04 PM
$OSTX I don't know why, but i bought another 12k shares at 1.89 earlier. Guess I am feeling lucky.
0 · Reply
flywithfitz81
flywithfitz81 Oct. 27 at 5:55 PM
$OSTX Base Case: Catalysts timeline that could impact price Upcoming biomarker data (immune activation correlation) expected in upcoming months. Stock Titan+1 Further regulatory meetings (e.g., with EMA, MHRA) and potential submission of BLA/MAA. Stock Titan+1 Potential commercialization / partnership announcements if approval pathway advances. Market reaction to any negative surprise (e.g., regulatory push-back, dilution) could cause sharp move downward. Price prediction: Under the base scenario, OSTX goes from ~US$1.90 today to: ~US$3.00 in 30 days ~US$4.00 in 60 days ~US$5.50 in 90 days ~US$7.50 in 180 days This assumes positive regulatory/bio data, maintain runway, no major negative surprises. If a major partnership or accelerated path is confirmed, the upside could be much higher (bull scenario). Conversely, any regulatory setback or dilution risk could send the price lower (bear scenario). https://www.stocktitan.net/news/OSTX/?utm_source=chatgpt.com
1 · Reply
MadMaverick
MadMaverick Oct. 27 at 5:05 PM
🚨 Biotech traders, watch $OSTX Game-changing data just dropped: 🧬 2-year Overall Survival: → 73.8% for lung-only mets vs. → 30% historical comparator (p < 0.0001) 📅 Regulatory meetings with MHRA, FDA & EMA slated for Dec. 2025 ⚡️ Fast-track potential for osteosarcoma + solid tumor therapies This could be a pivotal moment in rare cancer treatment. Communicated Disclaimer - https://stockresearchtoday.com/groundbreaking-treatments-for-solid-tumors/ Other stocks moving up today: $CODX $CLIK $BKYI
0 · Reply
LioGod
LioGod Oct. 27 at 4:27 PM
$OSTX damn could we see a 2$?
0 · Reply
Orlandotrader
Orlandotrader Oct. 27 at 3:46 PM
$OSTX Could we finally be on the Ascent!!!
0 · Reply
flywithfitz81
flywithfitz81 Oct. 27 at 11:16 AM
I have completely blown up my last portfolio over and shifted into more aggressive stance to match the mood of the market. I am taking higher risks and utilizing Stop Losses more aggressively. I have increases quite substantially my positions in $PSTV $OSTX and reinforced my position in $SPCB. I had a large portion of $CNC hit a sell limit, but I bought back in during the previous dip. I am still not investing in the Tech/AI bubble and have been hedging away from banks. I have a certain value of RSU in $AVPT, so that is all the tech risk I am willing to take. As for the banks, I am a little worried about over-leverage and sub prime risks. I am keeping more cash in reserve/foreign exchange for now. My expectations are very bullish here: Ticker / % Portfolio / Avg Cost AVPT / 40% / $9.50 CNC / 25% / $32.50 OSTX / 8% / $1.49 SPCB / 7% / $8.97 PSTV / 7% / $0.49 SHLD / 7% / $58.70 PSNY / 3% / $0.840 URG / 3% / $1.55 Follow if interested, I will re-post this periodically to track.
2 · Reply
flywithfitz81
flywithfitz81 Oct. 27 at 9:17 AM
0 · Reply
TeaBaggerVance
TeaBaggerVance Oct. 25 at 5:57 PM
$OSTX I’m gonna try to update how many watchers our board has every week for anyone who is interested in the data. 10/18 - 2,041 10/25 - 2,063 (+22)
1 · Reply
crisio
crisio Oct. 25 at 11:09 AM
$OSTX Is there any information about OSTX moving to the Nasdaq? I hope OSTX moves to the Nasdaq AMEX is not reliable
1 · Reply
ACstranger
ACstranger Oct. 25 at 4:09 AM
$OSTX clearly accumulation yesterday and manipulation after hours.
0 · Reply
Ryanrable
Ryanrable Oct. 25 at 1:43 AM
$OSTX Gerald C is employed here… you’ve been warned….
2 · Reply
TeaBaggerVance
TeaBaggerVance Oct. 24 at 11:22 PM
$OSTX Daily looking like the bottom might’ve been found a few days ago 📈📈📈
0 · Reply
IAmMsMoneyMaker
IAmMsMoneyMaker Oct. 24 at 7:59 PM
$OSTX NEW HIGHER DAILY HIGHS GOING INTO THE CLOSE! 💪💪
0 · Reply
IAmMsMoneyMaker
IAmMsMoneyMaker Oct. 24 at 7:10 PM
$OSTX DON’T BE LATE!!! ⏰ I AM FEELIN’ A HUGE WIN SOON!!! THIS COMPANY HAS BEEN SOLID. THEY DO WHAT THEY SAY! TIMING IS REALLY EVERYTHING…⏳⌛️
1 · Reply
lisaLis
lisaLis Oct. 24 at 6:14 PM
0 · Reply
lisaLis
lisaLis Oct. 24 at 6:13 PM
$OSTX Buy the dips!!!
0 · Reply
LioGod
LioGod Oct. 24 at 4:53 PM
$OSTX allergic to 1.90
0 · Reply